This case underscores the importance of early diagnosis and aggressive management in patients with TTP associated with severe ADAMTS13 deficiency, emphasizing the effectiveness of therapeutic plasma exchange and Rituximab in treating this rare condition. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.